OTC · Biotechnology

Healios K.K. (HLOSF) Stock

$1.80 +0.00% OTC: HLOSF Healthcare

Healios K.K. is a biotechnology firm specializing in the innovation, development, production, and commercialization of cell therapy and regenerative medicine products, with operations spanning Japan, Europe, and the United States.

Valuation

MetricValue
Price$1.80
Market Cap$243.00M
P/E Ratio-9.76
P/B Ratio3.93
P/S Ratio430.55
EPS (TTM)$-20.39
52-Week High$4.45
52-Week Low$1.80
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-75.40%
ROA-13.35%
ROCE-21.38%
Gross Margin-529.73%
Operating Margin-3275.00%
Net Margin-2133.65%
Debt/Equity0.34
Current Ratio2.05

Annual Financials (USD)

Metric20212022202320242025
Revenue$41.0M$90.0M$121.0M$560.0M$104.0M
Operating Profit$-5.4B$-5.2B$-3.4B$-2.8B$-3.4B
Net Profit$-4.9B$-5.2B$-3.8B$-4.2B$-2.2B
EPS$-93.40$-90.69$-56.22$-47.87$-20.39
Op Margin-13131.7%-5754.4%-2792.6%-507.7%-3272.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$24.0B$15.0B$15.2B$14.2B$17.1B
Total Liabilities$15.3B$10.7B$11.3B$12.1B$12.2B
Cash$15.1B$7.2B$6.7B$3.7B$5.7B
Borrowings$12.0B$7.1B$4.5B$2.7B$2.6B

Latest News

Exploring High Growth Tech Stocks In Asia May 2026 Simply Wall St. · May 18, 2026 HEALIOS K.K. to Present at Jefferies Global Healthcare Conference GlobeNewswire · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.1B$-4.6B$-2.8B$-1.8B$-3.2B
Investing Cash Flow$-1.0B$-1.2B$-1.1B$-1.7B$-1.3B
Financing Cash Flow$229.0M$281.0M$2.8B$328.0M$1.3B
Net Cash Flow$1.2B$-7.9B$-525.0M$-3.0B$2.0B
Free Cash Flow$-5.4B$-4.9B$-2.9B$-2.1B$-3.3B

Valuation & Return Ratios

MetricValue
PEG Ratio-0.36
EV / EBITDA-12.33
FCF Yield-12.13%
Quick Ratio2.05
Interest Coverage-0.91
Return 1Y-47.60%
Return 3Y-87.63%
Return 5Y—

Ownership

Insiders Held22.10%
Institutions Held37.04%
Institutions Float Held47.55%
Institutional HolderSharesReport Date
American Century ETF Trust-Avantis International Small Cap Equity ETF2002026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVCTFAvacta Group Plc $0.94 +3.71% -7.36 $440.30M 0.00%
BOVNFBioInvent International AB (publ) $3.29 +0.00% -4.47 $216.40M 0.00%
CLVLYClinuvel Pharmaceuticals Limited $6.83 -2.57% 13.94 $344.42M 0.44%
CMVLFCellectis S.A. $3.47 +12.66% -4.24 $251.93M 0.00%
CRLBFCresco Labs Inc. $0.68 +5.99% -1.70 $240.87M 0.00%

About Healios K.K.

Healios K.K. is a biotechnology firm specializing in the innovation, development, production, and commercialization of cell therapy and regenerative medicine products, with operations spanning Japan, Europe, and the United States. The company's robust pipeline features several advanced cellular and tissue-based therapies: iPSC-derived regenerative medicines HLCR011 and HLCR012, which target age-related macular degeneration; HLCL041, an iPSC regenerative medicine for metabolic liver disease; HLCM051, a regenerative treatment for ischemic stroke and acute respiratory distress syndrome; and HLCN061, currently under development for solid tumor indications. Furthermore, Healios K.K. maintains a collaborative research agreement with Hyogo Medical University, focusing on eNK cell-based cancer immunotherapies for mesothelioma. Founded in 2011 as Retina Institute Japan, K.K., the company rebranded to Healios K.K. in September 2013 and is headquartered in Tokyo, Japan.

Healios K.K. is headquartered in JP.

Healios K.K. (HLOSF) stock trades at $1.80 with a market capitalization of $243.00M. The stock is valued at a price-to-earnings (P/E) ratio of -9.76, price-to-book of 3.93, price-to-sales of 430.55. Over the past 52 weeks the stock has ranged between $1.80 and $4.45, and currently trades 59.6% below its 52-week high.

On profitability, Healios K.K. generates a return on equity (ROE) of -75.40%, return on capital employed of -21.38%, an operating margin of -3275.00%, a net profit margin of -2133.65%.

Official website: www.healios.co.jp

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides